“Looking down the microscope at the dying tumor cells, we were quite excited, especially when the experiment was repeated and showed the same effect twice. We had used non cancerous cells for a long time in similar experiments and they had not died... Hamlet is ready to become a new drug.”Daily Telegraph
Press Release, Lund October 6, 2020 BAMLET (bovine α-lactalbumin made lethal to tumour cells) is a molecular complex formed by bovine α-lactalbumin and oleic acid….
Press Release, Lund September 25, 2020 Hamlet Pharma is pleased to announce that the clinical development of Alpha1H therapy in bladder cancer will be accelerated….
Press Release, Lund May 12, 2020 A patent licensing agreement has been signed between Hamlet Pharma AB and Linnane Pharma AB to secure the development…
”Scientists are testing a modified protein found in breast milk to see whether it can be used to treat cancer. Researchers using a synthetic version of the chemical at Lund University, Sweden, are building on studies begun in 1995 when compounds derived from breast milk seemed to kill cancer cells without harming healthy cells. Results from the first trial, in Prague, on patients with bladder cancer are expected in May or June. It is hoped the drug may also be effective in tackling colon cancer and brain tumors.The Times
“There’s something magical about Hamlet’s ability to target tumour cells and kill them.”Daily Mail
”The final results include a range of very exciting, molecular technologies and tissue analyses that will provide more precise tools to define the drug effect in each patient. A positive outcome of the bladder cancer study would help reinforce the potential of this new type of cancer therapy.South China Morning Post
“We were looking for novel antimicrobial agents, and new breast milk is a very good source of these. To our amazement, when we added this compound of milk, the tumour cells died. It was a totally serendipitous discovery.”Daily Mail
“It’s a bit like pouring cement on (cancer) cells. They just can’t make new molecules and survive any longer.”BBC Science Focus Magazine
“Hamlet Pharma AB is about to embark on the next phase in the clinical development of its novel cancer therapy ... At a time when the industry is focused on highly priced game-changing molecules with well-defined mechanisms, Hamlet appears like an outlier, althoughBioWorldHamlet building the case for 'bulldozer' cancer drug
one with a lengthy scientific underpinning.”